Prokidney (PROK) Operating Expenses (2021 - 2026)

Prokidney (PROK) has 6 years of Operating Expenses data on file, last reported at $45.2 million in Q1 2026.

• Operating Expenses for Q1 2026 came in at $45.2 million, up 8.51% year-over-year; the trailing twelve-month figure through Mar 2026 was $169.4 million (down 8.56% YoY), and the FY2025 annual result was $165.9 million, down 9.72% from the prior year.
• Operating Expenses retreated to $45.2 million in Q1 2026 per PROK's latest filing, from $45.6 million in the prior quarter.
• Over five years, Operating Expenses peaked at $66.5 million in Q1 2022 and troughed at $20.7 million in Q2 2022.
• A 5-year average of $41.1 million and a median of $40.9 million in 2023 frame the typical range for Operating Expenses.
• The sharpest annual moves came in 2022 and 2023: Operating Expenses soared 14501997.9% in 2022, then tumbled 38.5% in 2023.
• A 5-year view of Operating Expenses shows it stood at $30.2 million in 2022, then declined by 19.93% to $24.2 million in 2023, then jumped by 113.33% to $51.6 million in 2024, then decreased by 11.72% to $45.6 million in 2025, then declined by 0.96% to $45.2 million in 2026.
• Business Quant data shows PROK's Operating Expenses at $45.2 million in Q1 2026, $45.6 million in Q4 2025, and $38.8 million in Q3 2025.